Jim Cramer Likes This Industrial Stock 'Even Up Here,' As For ImmunityBio? 'It's Risky'

Zinger Key Points
  • ImmunityBio "is losing a lot of money," Cramer noted.
  • "If you like Air Lease, you’re going to love Boeing," he added.

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Trane Technologies plc TT so much. "I still like it, even up here," he noted.

Trane’s shares have surged around 32% over the past six months.

"I like these guys," Cramer said when asked about Palantir Technologies Inc. PLTR.

When asked about Walmart Inc. WMT, he said, "Man, that stock goes down every day. You know why? Because it used to go up every day. I think this is a good level to start buying Walmart." He added that Costco Wholesale Corporation COST is better.

Cramer said ImmunityBio, Inc. IBRX is losing a lot of money. "It’s a company that if they don’t get the approval that you want, it could be dangerous. As long as you accept the risk, then I’m fine, but it’s a very risky stock," he noted.

Don’t forget to check out our premarket coverage here

The "Mad Money" host said he doesn’t know what Ellington Financial EFC owns. "I’m going to have to be a little more circumspect than you are," he added.

Cramer said he likes Air Lease Corporation AL. "But I got to tell you, if you like Air Lease, you’re going to love The Boeing Company BA," he added.

Price Action: Shares of Boeing gained 1% to close at $233.87, while Air Lease rose 2.3% to $39.68 on Friday. Ellington Financial gained 0.9% to $13.12, while ImmunityBio rose 2.7% to $3.78 during Friday’s session. Costco gained 0.6% to $596.25, while Walmart shares fell 0.9% to settle at $154.34. Palantir shares rose 1.1%, while Trane Technologies rose 0.9% on Friday.

Now Read This: Investor Sentiment Increases As S&P 500 Reaches 2023 Record

Market News and Data brought to you by Benzinga APIs
Posted In: Long IdeasNewsPenny StocksSmall CapTop StoriesMarketsMediaTrading IdeasCNBCJim Cramermad money Lightning Round
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...